Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,139.3
-2.1 (-0.07%)

 

  • STI Straits Times Index
    3,139.3
    -2.1 (-0.07%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,792.9
    -10.8 (-0.60%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,084.7
    151.8 (0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,699.9
    48.2 (1.82%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,420.5
    325.9 (1.41%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,811.8
    -12.5 (-0.21%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,309.0
    6.0 (0.26%)
    Index delayed 20 minutes
  • XAO XAO
    6,269.5
    -24.4 (-0.39%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 743.3M
  • Value: 842.1M
  • Rise: 139
  • Fall: 184
  • Unch: 526

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.114+0.005
Genting Sing1.030+0.010
AusGroup^0.041-0.005
Allied Tech0.019-
Ezion0.072-
Ascendas Reit2.570-0.030
SingTel3.110-
YZJ Shipbldg SGD1.110+0.020
ThaiBev0.650-
Asian Pay Tv Tr0.355-

World Indices

World Indices
Name Last Change
Nasdaq 7,895.8 -114.2
HSI 27,084.7 +151.8
HSCEI 10,557.0 +94.9
Jakarta 5,811.8 -12.5
Nikkei 225 23,420.5 +325.9
SSE Comp 2,699.9 +48.2
Shanghai A 2,827.5 +50.5
Shanghai B 282.9 +3.1
ShenZhen A 1,468.0 +24.3
ShenZhen B 957.0 +9.0
Taiwan W 10,760.2 -68.4
PSE Comp 0.0
KOSPI 2,309.0 +6.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

QT Vascular QT VASCULAR LTD.
Quotes 10 Minutes Delayed. Updated at 18 Sep 2018 16:56
Last (SGD): 0.011 Change: - High: 0.011 Remarks: -
Change (%): - Low: 0.011
Open 0.011 Yesterday's Close 0.011
Buy Price 0.011 Sell Price 0.012
Buy Volume ('000) 14,037.1 Sell Volume ('000) 7,689.0
Cumulative Volume ('000) 3,113.7 Cumulative Value 34,251
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.01653 Trailing EPS (SGD) e 0.01845 NAV (SGD) b 0.0181
PE a - Trailing PE f 0.596 Price / NAV b 0.6077
Dividend (SGD) d - Cash In Hand (SGD) g 0.0139 Issued & Paid-up Shares c 2,092,632,000
Dividend Yield (%) d - Price / Cash In Hand g 0.791 Treasury Shares h -
Beta - 75 Daysi 0.993 R-Squared - 75 Days(%)i 1.40 Market Cap (M) 23.019
Beta - 500 Daysi 0.990 R-Squared - 500 Days (%)i 1.26 Free Float (%) 82.1
Piotroski F Score 2 Exchange Code 5I0 Par Value ( SGD ) n.a.
Under CPF Investment Scheme (CPFIS) Yes
Sector & Industry Manufacturing - Biotechnology
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 20 Aug 2018.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QT Vascular SGX 23.019 - 0.596 0.6077 -
Industry Biotechnology SGX 1,990.928 6.266 4.804 0.6801 4.674
Medical & Biotechnology SGX 1,128.996 22.238 20.069 1.3892 1.746
Index FTSE ST Catalist Index SGX 88.183 - - 0.9489 1.690
Local Peer Lonza SGX 5,937.213 5.989 4.911 0.6806 4.702
Local Peer Suntar Eco-City^ SGX 12.552 - - 0.6098 -
Global Peer AMGEN INC NASDAQ 129,978.690 65.679 54.983 8.7181 2.556
Global Peer GILEAD SCIENCES INC NASDAQ 94,347.625 20.386 42.730 4.3534 2.884
Global Peer AMGEN-T HKEx 647,272.000 41.971 34.779 5.5338 4.000
Global Peer CSL ASX 92,930.677 41.649 41.649 16.8293 1.111
Global Peer BIOGEN INC NASDAQ 67,362.539 26.530 22.695 5.4941 -
Global Peer CELGENE CORP NASDAQ 61,333.254 20.862 21.920 17.8813 -
Global Peer ILLUMINA INC NASDAQ 51,041.340 70.402 78.767 15.6712 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 44,927.448 170.703 108.233 16.7252 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 41,762.699 34.845 26.246 5.8113 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 26,255.019 59.226 - 2.9946 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), TILRAY INC (NASDAQ), WUXI BIO (HKEx), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE-B (HKEx), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), FIBROGEN INC (NASDAQ), LOXO ONCOLOGY INC (NASDAQ), EXELIXIS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 3SBIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), GENSCRIPT BIO (HKEx), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MYRIAD GENETICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), OPKO HEALTH INC (NASDAQ), REPLIGEN CORP (NASDAQ), REGENXBIO INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ACCELERON PHARMA (NASDAQ), GENOMIC HEALTH INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), TESARO INC (NASDAQ), INTREXON CORP (NYSE), ENANTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ENDOCYTE INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), IMMUNOGEN INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), UNIQURE N.V. (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), RETROPHIN INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), HAOHAI BIOTEC (HKEx), RHYTHM PHARMACEUTICALS INC (NASDAQ), ASCLETIS-B (HKEx), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), VANDA PHARMACE INC (NASDAQ), GERON CORP (NASDAQ), AVROBIO INC (NASDAQ), MACROGENICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CAREDX INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), RADIUS HEALTH INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), EPIZYME INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), KURA ONCOLOGY INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), INSYS THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), MESOBLAST LTD (ASX), REPLIMUNE GROUP INC (NASDAQ), CKLIFE SCIENCES (HKEx), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), GTX INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CHEMOCENTRYX INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), LEE'S PHARM (HKEx), ELOXX PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MEDICINOVA INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ESSEX BIO-TECH (HKEx), MERUS B V (NASDAQ), SINOVAC BIOTECH (NASDAQ), CYTOKINETICS INC (NASDAQ), DERMIRA INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), RESTORBIO INC (NASDAQ), SAVARA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), KADMON HLDGS INC (NYSE), KEZAR LIFE SCIENCES INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), KERYX BIOPHARMACEUTICALS (NASDAQ), ZAFGEN INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEPTUNE TECHNOLOGIES & BIORESSOURCE (NASDAQ), CORIUM INTERNATIONAL INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SYNLOGIC INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), RTI SURGICAL INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AFFIMED N V (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), MANNKIND CORPORATION (NASDAQ), ATHERSYS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), NEON THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IMV INC (NASDAQ), ARDELYX INC (NASDAQ), AXOVANT SCIENCES LTD (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), JOUNCE THERAPEUTICS INC (NASDAQ), TOCAGEN INC (NASDAQ), COMPUGEN (NASDAQ), KAMADA (NASDAQ), AGENUS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BBI LIFE SCI (HKEx), HARVARD BIOSCIENCE INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), COHBAR INC (NASDAQ), CCMDBIO (Bursa), CUE BIOPHARMA INC (NASDAQ), CHIMERIX INC (NASDAQ), BIONOMICS LTD (ASX), MIRAGEN THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), RECRO PHARMA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), IMMUNE DESIGN CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), PLURISTEM THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), CONTRAFECT CORP (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), XOMA CORP (NASDAQ), RESAPP HEALTH LIMITED (ASX), CHAMPIONS ONCOLOGY INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), TREVENA INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ONCOMED PHARMACEUTICALS INC (NASDAQ), PFENEX INC (NYSE American), XBIOTECH INC (NASDAQ), VACCINEX INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), PORT (SET), LEAP THERAPEUTICS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), AVITA MEDICAL LTD (ASX), NEWLINK GENETICS CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), OPHTHOTECH CORPORATION (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), IBIO INC (NYSE American), UNI-BIO GROUP (HKEx), SOPHIRIS BIO INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), EDAP TMS S.A. ADS EACH REPR 1 ORD SHARE FRF0.8 (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), SUNESIS PHARMACEUTICALS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), ASTERIAS BIOTHERAPEUTICS INC (NYSE American), ONCOLYTICS BIOTECH INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CT ENTERPRISE (HKEx), AQUINOX PHARMACEUTICALS INC (NASDAQ), ONCOBIOLOGICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), IMUGENE LIMITED (ASX), ADVAXIS INC (NASDAQ), CURIS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), VERSARTIS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NYSE American), TRILLIUM THERAPEUTICS INC (NASDAQ), PHYLOGICA LIMITED (ASX), GENOCEA BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), VERMILLION INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), EXTRAWELL PHAR (HKEx), CEL-SCI CORP (NYSE American), CAPRICOR THERAPEUTICS INC (NASDAQ), IMMURON LIMITED (ASX), APTOSE BIOSCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), BIOSINO BIO-TEC (HKEx), PATRYS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), FACTOR THERAPEUTICS LIMITED (ASX), CO DIAGNOSTICS INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), VICAL INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), ISORAY INC (NYSE American), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), PHOSPHAGENICS LTD (ASX), OVASCIENCE INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADR EA REPR 2 ORD SHS (NYSE American), REGENEUS LTD (ASX), NANOVIRICIDES INC (NYSE American), ARSANIS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), EDGE THERAPEUTICS INC (NASDAQ), CELLMID LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), BIONANO GENOMICS INC (NASDAQ), ADALTA LTD (ASX), ORTHOCELL LIMITED (ASX), ATYR PHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADR EACH REP 2 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), ORAGENICS INC (NYSE American), FIBROCELL SCIENCE INC (NASDAQ), RHINOMED LIMITED (ASX), VAXART INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), PRANA BIOTECHNOLOGY SPON ADR EA REPR 60 ORD (POST REV SPLIT) (NASDAQ), COLLPLANT HOLDINGS LTD SPON ADR EACH REP 50 ORD(POST REV SPLT) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), SENESTECH INC (NASDAQ), NEURALSTEM INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), PRANA BIOTECHNOLOGY (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), HISTOGENICS CORP (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), HAO WEN HLDGS (HKEx), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), BIOXYNE LIMITED (ASX), TROVAGENE INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), MEDIBIO LIMITED (ASX), BIO-PATH HOLDINGS INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), ALLIQUA BIOMEDICAL INC (NASDAQ), INTELLIPHARMACEUTICS INTL INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), OPGEN INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), MEGASUN (Bursa), AMPLIA THERAPEUTICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), VITAL THERAPIES INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), OHR PHARMACEUTICAL INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PRECIPIO INC (NASDAQ), AMPLIPHI BIOSCIENCES CORPORATION (NYSE American), CELLECTAR BIOSCIENCES INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), MGRC (Bursa), STELLAR BIOTECHNOLOGIES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), NANOLLOSE LTD (ASX), BIOCEPT INC (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), BIOTRON (ASX), RXI PHARMACEUTICALS CORP (NASDAQ), CCP TECHNOLOGIES LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), BIOBLAST PHARMA LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), IMMUNOCELLULAR THERAPEUTICS LTD (NYSE American), CYTORI THERAPEUTICS INC (NASDAQ), MEMPHASYS LTD (ASX), ALCHEMIA LIMITED (ASX), AURIS MEDICAL HOLDING AG (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BPH ENERGY LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.001
-8.33 %
10 Days --0.001
-8.33 %
20 Days --0.002
-15.38 %
Medium Term Return 3 Months --0.001
-8.33 %
6 Months --0.005
-31.25 %
1 Year -+0.003
+37.50 %
Long Term Return 2 Years --0.068
-86.08 %
3 Years --0.083
-88.30 %
Annualised Return Annualised --
-51.09 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.006 - 0.022 Change From 1 Year Low +0.005 % Change From 1 Year Low (%) +83.33
Change From 1 Year High -0.011 % Change From 1 Year High (%) -50.00
2 Years Range 0.006 - 0.115 Change From 2 Years Low +0.005 % Change From 2 Years Low (%) +83.33
Change From 2 Years High -0.104 % Change From 2 Years High (%) -90.43
5 Years Range 0.006 - 0.560 Change From 5 Years Low +0.005 % Change From 5 Years Low (%) +83.33
Change From 5 Years High -0.549 % Change From 5 Years High (%) -98.04
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The Group collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

IPO Performance

Listing Date 29 Apr 2014 Full Subscription Rate (x) -
No of Placement Shares (M) 196.43 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.340 First Week Close (SGD) 0.345
Current vs IPO Price (%) -96.07 First Day Gain (%) +21.43 First Week Gain (%) +23.21

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2017 Dec 2017 Part 1(0.91 MB)
Part 2(0.08 MB)
Annual Report 2016 Dec 2016 Part 1(1.60 MB)
Part 2(0.47 MB)
Annual Report 2015 Dec 2015 Part 1(0.82 MB)
Part 2(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(2.05 MB)
Part 2(0.42 MB)
Annual Report 2013 Dec 2013 Part 1(1.04 MB)
IPO Prospectus
IPO Prospectus 2014 Apr 2014 Part 1(3.55 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
18 Sep 2018 0.011 0.011 0.011 0.011 3,113,700 0.0110
17 Sep 2018 0.011 0.012 0.011 0.011 4,600,000 0.0110
14 Sep 2018 0.011 0.012 0.011 0.011 115,100 0.0110
13 Sep 2018 0.012 0.012 0.012 0.012 1,576,000 0.0120
12 Sep 2018 0.012 0.012 0.011 0.012 1,090,400 0.0119
11 Sep 2018 0.012 0.012 0.012 0.012 100,000 0.0120
10 Sep 2018 0.012 0.013 0.012 0.012 10,789,000 0.0120
07 Sep 2018 0.012 0.012 0.012 0.012 1,245,000 0.0120
06 Sep 2018 0.012 0.012 0.012 0.012 1,650,000 0.0120
05 Sep 2018 0.013 0.013 0.012 0.012 1,617,000 0.0123
04 Sep 2018 0.013 0.013 0.012 0.012 3,500,000 0.0128
03 Sep 2018 0.012 0.013 0.012 0.013 2,911,500 0.0128
31 Aug 2018 0.012 0.013 0.012 0.012 5,170,100 0.0120
30 Aug 2018 0.012 0.012 0.012 0.012 2,345,000 0.0120
29 Aug 2018 0.012 0.012 0.011 0.011 2,570,000 0.0116
28 Aug 2018 0.012 0.012 0.012 0.012 800,000 0.0120
27 Aug 2018 0.012 0.012 0.012 0.012 1,294,600 0.0120
24 Aug 2018 0.011 0.012 0.011 0.012 4,358,800 0.0120
23 Aug 2018 0.012 0.012 0.012 0.012 6,990,000 0.0120
21 Aug 2018 0.012 0.013 0.012 0.013 4,027,100 0.0122
20 Aug 2018 0.013 0.013 0.012 0.013 602,800 0.0120
17 Aug 2018 0.012 0.012 0.012 0.012 1,100,000 0.0120
Summary
Current 2 Weeks
(05 Sep 2018 to 18 Sep 2018)
0.013 0.013 0.011 0.011 25,896,200 -
Previous 2 Weeks
(21 Aug 2018 to 04 Sep 2018)
0.012 0.013 0.011 0.012 33,967,100 -
4 Weeks from
(23 Jul 2018 to 20 Aug 2018)
0.012 0.013 0.011 0.013 112,910,300 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.